Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Alimentary Health presents new immunomodulatory agents

May 21, 2010

TOL-101 antibody modulates T-cell responses in vitro and in vivo

May 21, 2010

Biogen Idec claims new lysophospholipid S1P1 receptor agonists

May 20, 2010

Bayer and AstraZeneca claim new glucocorticoid receptor ligands

May 20, 2010

Soligenix completes enrollment in phase II trial of orBec in acute GVHD prevention

May 14, 2010

Phase I safety data reported for orphan drug QPI-1002

May 11, 2010

Vascular Biogenics (d/b/a VBL Therapeutics) discloses novel antiinflammatory agents

May 10, 2010

Synergistic tolerogenic effects seen with RGI-2001 and anti-thymocyte globulin in vivo

May 7, 2010

Jak3 inhibitor R-348 prevents acute rejection and OAD in rodent model of transplantation

May 4, 2010

FDA issues complete response letter regarding Bristol-Myers Squibb's BLA for belatacept

May 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...